Statistics for Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia
Total visits
| views | |
|---|---|
| Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia | 40 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:61f75ff7-7ed8-4f2c-8286-cc4fe065de1c | 5 |
Top country views
| views | |
|---|---|
| United States | 36 |
Top city views
| views | |
|---|---|
| Wilmington | 29 |
| Baltimore | 2 |
| Fairfield | 2 |
| Washington | 2 |
| Ann Arbor | 1 |